[How far should the serum concentration of inorganic phosphate be lowered in patients with chronic uremia?].
作者信息
Eigler J, Grabensee B, Henning H V
出版信息
Med Welt. 1982 Jan 29;33(4):115-6.
PMID:7062836
Abstract
摘要
相似文献
1
[How far should the serum concentration of inorganic phosphate be lowered in patients with chronic uremia?].慢性尿毒症患者的血清无机磷酸盐浓度应降低多少？
Med Welt. 1982 Jan 29;33(4):115-6.
2
Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.慢性间歇性血液透析患者中的氢氧化铝、碳酸钙和醋酸钙
Clin Nephrol. 1996 Feb;45(2):111-9.
3
4
Aluminium hydroxide versus sucralfate as a phosphate binder in uraemia.氢氧化铝与硫糖铝作为尿毒症磷结合剂的比较
Br Med J (Clin Res Ed). 1983 Apr 30;286(6375):1379-81. doi: 10.1136/bmj.286.6375.1379.
5
Calcium carbonate: a suitable alternative to aluminum hydroxide as phosphate binder.碳酸钙：作为磷酸盐结合剂，是氢氧化铝的合适替代品。
Kidney Int Suppl. 1988 Mar;24:S184-5.
6
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
7
[Aluminum hydroxide treatment of hyperphosphatemia in uremia].[氢氧化铝治疗尿毒症高磷血症]
Lakartidningen. 1972 May 3;69(19):2319-20.
8
[Aluminum poisoning by phosphate binders in kidney insufficiency].[肾功能不全患者中磷酸盐结合剂导致的铝中毒]
Verh Dtsch Ges Inn Med. 1977;83:1313-5.
9
Antacid induction of phosphate depletion syndrome in renal failure.肾衰竭中抗酸剂诱发的磷酸盐耗竭综合征
West J Med. 1974 Feb;120(2):157-60.
10
Role of the control of phosphate in the progression of chronic renal failure.磷控制在慢性肾衰竭进展中的作用。
Miner Electrolyte Metab. 1982 Mar;7(3):127-33.
Zotero 插件